Epilepsy as Central Nervous System Involvement in Patient with ANCA-Associated Vasculitis: A Case Report
Main Article Content
Abstract
Central nervous system (CNS) involvement by antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a rare presentation. The affected nerve structure determines the symptoms of AAV. Presentation as seizures can make early diagnosis difficult by necessitating the ruling out of other etiologies, which increases mortality in these patients. Serological and imaging studies facilitate the identification of AAV and initiation of timely treatment focused on remission of the autoimmune pathology. We present the case of a young female patient who, after diagnosis with AAV by renal biopsy, presented with several epileptic seizures. With angioresonance, we evidenced vascular involvement and began remission treatment with an adequate resolution of the seizures.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Paroli M, Gioia C, Accapezzato D. New Insights into Pathogenesis and Treatment of ANCA-Associated Vasculitis: Autoantibodies and Beyond. Antibodies (Basel). 2023 Mar 21
II. Fragoulis GE, Lionaki S, Venetsanopoulou A, Vlachoyiannopoulos PG, Moutsopoulos HM, Tzioufas AG. Central nervous system involvement in patients with granulomatosis with polyangiitis: a single-center retrospective study. Clin Rheumatol. 2018 Mar;37(3):737-747. doi: 10.1007/s10067-017-3835-y. Epub 2017 Sep 15.
III. Zheng Y, Zhang Y, Cai M, Lai N, Chen Z, Ding M. Central Nervous System Involvement in ANCA-Associated Vasculitis: What Neurologists Need to Know. Front Neurol. 2019 Jan 10;9:1166. doi: 10.3389/fneur.2018.01166.
IV. Graf J. Central Nervous System Disease in Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis. Rheum Dis Clin North Am. 2017 Nov;43(4):573-578. doi: 10.1016/j.rdc.2017.06.006.
V. Wirrell E. Evaluation of First Seizure and Newly Diagnosed Epilepsy. Continuum (Minneap Minn). 2022 Apr 1;28(2):230-260. doi: 10.1212/CON.0000000000001074.
VI. Migdady I, Rosenthal ES, Cock HR. Management of status epilepticus: a narrative review. Anaesthesia. 2022 Jan;77 Suppl 1:78-91. doi: 10.1111/anae.15606.
VII. Yokoseki A, Saji E, Arakawa M, Kosaka T, Hokari M, Toyoshima Y, et al. Hypertrophic pachymeningitis: significance of myeloperoxidase anti-neutrophil cytoplasmic antibody. Brain (2014) 137(Pt 2):520–36. doi: 10.1093/brain/awt314
VIII. Ferlazzo E, Gambardella A, Bellavia M, Gasparini S, Mumoli L, Labate A, Cianci V, Russo C, Aguglia U. Positivity to p-ANCA in patients with status epilepticus. BMC Neurol. 2014 Jul 17;14:148. doi: 10.1186/1471-2377-14-148.
IX. Sherri A, Mortada MM, Makowska J, Lewandowska-Polak A. Primary angiitis of the CNS and ANCA-associated vasculitis: from pathology to treatment. Rheumatol Int. 2023 Sep 30. doi: 10.1007/s00296-023-05461-9.
X. Sánchez-Román E, Monternach-Aguilar F, Reyes-Vaca JG, Rodríguez Leyva I (2021) Challenging presentation of primary vasculitis of the central nervous system. Cereb Circ Cogn Behav. https:// doi.org/10.1016/j.cccb.2021.100027